International variation in management of screen-detected ductal carcinoma in situ of the breast

European Journal of Cancer

Volumn 50, Issue 15, 2014, Pages 2695-2704

  Ponti, Antonio ^a   Lynge, Elsebeth ^b   James, Ted ^c   Májek, Ondřej ^c   Von Euler Chelpin, My ^d   Anttila, Ahti ^e   Fitzpatrick, Patricia ^f   Mano, Maria Piera ^a   Kawai, Masaaki ^g   Scharpantgen, Astrid ^h   Fracheboud, Jacques ⁱ   Hofvind, Solveig ^j   Vidal, Carmen ^k   Ascunce, Nieves ^l   Salas, Dolores ^m   Bulliard, Jean Luc ⁿ   Segnan, Nereo ^a   Kerlikowske, Karla ^o   Taplin, Stephen ^p  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF VERMONT   (United States)

^d MASARYK UNIVERSITY   (Czech Republic)

^e FINNISH CANCER REGISTRY   (Finland)

^f National Cancer Screening Service   (Ireland)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h Programme Mammographie   (Luxembourg)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j CANCER REGISTRY OF NORWAY   (Norway)

^k CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^l INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^m Centre for Public Health Research   (Spain)

ⁿ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

Axillary staging; Breast cancer; Cancer registration; Ductal carcinoma in situ (DCIS); Overtreatment; Screening mammography

Indexed keywords

AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DIAGNOSIS; EUROPE; FEMALE; HUMAN; INTERNATIONAL COOPERATION; JAPAN; LYMPH NODE DISSECTION; MIDDLE AGED; OUTCOME ASSESSMENT; PROCEDURES; RADIOTHERAPY; SEGMENTAL MASTECTOMY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; EARLY DETECTION OF CANCER; EUROPE; FEMALE; HUMANS; INTERNATIONAL AGENCIES; JAPAN; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RADIOTHERAPY; UNITED STATES;

EID: 84907260885     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.07.019     Document Type: Article

References (35)

1. B.A. Virnig, T.M. Tuttle, T. Shamliyan, and R.L. Kane Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes J Natl Cancer Inst 102 2010 170 178
2. V. Ernster, R. Ballard-Barbash, and W. Barlow Detection of DCIS in women undergoing screening mammography J Natl Cancer Inst 94 2002 1546 1554
3. M.J.M. Broeders, A. Scharpantgen, and N. Ascunce Comparison of early performance indicators for screening projects within the European Breast Cancer Network: 1989-2000 Eur J Cancer Prev 14 2005 107 116
4. E. Lynge, A. Ponti, and T. James Variation in detection of ductal carcinoma in situ (DCIS) in screening mammography. A survey within the International Cancer Screening Network (ICSN) Eur J Cancer 50 2014 185 192
5. B. Erbas, E. Provenzano, J. Armes, and D. Gertig The natural history of ductal carcinoma in situ of the breast: a review Breast Cancer Res Treat 97 2006 135 144
6. H.M. Kuerer, C.T. Albarracin, and W.T. Yang Ductal carcinoma in situ: state of the science and roadmap to advance the field J Clin Oncol 27 2009 279 288
7. K. Mokbel, and B. Cutuli Heterogeneity of ductal carcinoma in situ and its effects on management Lancet Oncol 7 2006 756 765
8. M.S. Moran, H.X. Bai, and E.E. Harris ACR appropriateness criteria for ductal carcinoma in situ Breast J 18 2012 8 15
9. British Association of Surgical Oncology Surgical guidelines for the management of breast cancer Eur J Surg Oncol 35 Suppl. 1 2009 1 22
10. M.R. Del Turco, A. Ponti, and U. Bick Quality indicators in breast cancer care Eur J Cancer 46 2010 2344 2356
11. S.M. Willems, C.H.M. van Deurzen, and P.J. van Diest Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review J Clin Pathol 65 2012 287 292
12. A. Brazda, J. Estroff, and D. Euhus Delays in time to treatment and survival impact in breast cancer Ann Surg Oncol 17 Suppl. 3 2010 291 296
13. L.J. Caldon, K.A. Collins, and D.J. Wilde Why do hospital mastectomy rates vary? Differences in the decision-making experiences of women with breast cancer Br J Cancer 104 2011 1551 1557
14. NCIN (National Cancer Intelligence Network) The non-invasive breast cancer report 2011 West Midlands Cancer Intelligence Unit Birmingham
15. B. Cutuli, C. Lemanski, and A. Fourquet Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience Br J Cancer 100 2009 1048 1054
16. A.P. Schouten van der Velden, J.A. Van Dijck, and T. Wobbes Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands Eur J Surg Oncol 33 2007 424 429
17. L.N. Van Steenbergen, A.C. Voogd, and J.A. Roukema Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands The Breast 23 2014 63 68
18. D. Dodwell, K. Clements, and G. Lawrence Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project Br J Cancer 97 2007 725 729
19. NICE (National Institute for Clinical Excellence) Guidelines on early and locally advanced breast cancer 2009 National Collaborating Centre for Cancer Cardiff
20. C.H. Van Deurzen, M.G. Hobbelink, R. van Hillegersberg, and P.J. van Diest Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review Eur J Cancer 43 2007 993 1001
21. M.J. Silverstein, A. Recht, and M.D. Lagios Consensus conference III: Image-detected breast cancer. State of the art diagnosis and treatment J Am Coll Surg 209 2009 504 520
22. M.J. Silverstein, R.J. Rosser, and E.D. Gierson Axillary lymph node dissection for intraductal breast carcinoma - is it indicated? Cancer 59 1987 1819 1824
23. M. Morrow Axillary surgery in DCIS: is less more? Ann Surg Oncol 15 2008 2641 2642
24. G.H. Lyman, S. Temin, and S.B. Edge Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update J Clin Oncol 32 2014 10.1200/JCO.2013.54.1177
25. M.R. Porembka, R.L. Abraham, J.A. Sefko, A.D. Deshpande, D.B. Jeffe, and J.A. Margenthaler Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 Seer data Ann Surg Oncol 15 2008 2709 2719
26. A. Kricker, and B. Armstrong Surgery and outcomes of ductal carcinoma in situ of the breast: a population-based study in Australia Eur J Cancer 40 2004 396 402
27. A. Ponti, M.P. Mano, and M. Tomatis Audit of breast cancer diagnosis and treatment in Italy, 2010 Epidemiol Prev 36 Suppl. 1 2012 87 95
28. Finnish Cancer Registry - Institute for Statistical and Epidemiological Cancer Research: Cancer in Finland 2008 and 2009. Cancer Statistics of the National Institute for Health and Welfare. Cancer Society of Finland. Publication No. 84, Helsinki; 2011.
29. J.R. Berson, and G.C. Wishart Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery Lancet Oncol 14 2013 348 357
30. R.S. Punglia, J.S. Stuart, and J.C. Weeks Treatment of ductal carcinoma in situ after excision. Would a prophylactic paradigm be more appropriate? J Natl Cancer Inst 105 2013 1527 1533
31. C.J. Allegra, D.R. Aberle, and P. Ganschow National Institutes of Health State-of-the-Science Conference statement: Diagnosis and management of ductal carcinoma in situ September 22-24, 2009 J Natl Cancer Inst 102 2010 161 169
32. L.J. Esserman, I.M. Thompson, and B. Reid Overdiagnosis and overtreatment in cancer: an opportunity for improvement JAMA 310 2013 797 798
33. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst 98 2006 599 609
34. F. Vrijens, S. Stordeur, and K. Beirens Effect of hospital volume on processes of car and 5-year survival after breast cancer: a population-based study on 25000 women The Breast 21 2012 261 266
35. E.M. Kesson, G.M. Allardice, and W.D. George Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13722 women BMJ 344 2012 10.1136/bmj.e2718.